Blue Path Capital Management, LLC Axonics, Inc. Transaction History
Blue Path Capital Management, LLC
- $133 Billion
- Q1 2024
A detailed history of Blue Path Capital Management, LLC transactions in Axonics, Inc. stock. As of the latest transaction made, Blue Path Capital Management, LLC holds 3,866 shares of AXNX stock, worth $264,936. This represents 0.2% of its overall portfolio holdings.
Number of Shares
3,866
Previous 3,874
0.21%
Holding current value
$264,936
Previous $267 Million
0.03%
% of portfolio
0.2%
Previous 0.23%
Shares
3 transactions
Others Institutions Holding AXNX
# of Institutions
245Shares Held
41.7MCall Options Held
213KPut Options Held
362K-
Vanguard Group Inc Valley Forge, PA5.04MShares$346 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.29MShares$294 Million0.01% of portfolio
-
Alpine Associates Management Inc. Englewood Cliffs, NJ1.81MShares$124 Million4.89% of portfolio
-
Fil LTD Hamilton, D01.72MShares$118 Million0.12% of portfolio
-
Mackenzie Financial Corp Toronto Ontario, A61.27MShares$86.9 Million0.13% of portfolio
About Axonics, Inc.
- Ticker AXNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 49,123,600
- Market Cap $3.37B
- Description
- Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...